Advancing Care in Pulmonary Arterial Hypertension
COMMITTED TO IMPACTING PRACTICE CARE
For more than 15 years, the IMPACT PH Program—powered by a distinguished, multidisciplinary faculty—has driven measurable improvements in patient outcomes through a curriculum that champions early diagnosis and evidence-based treatment, fundamentally transforming pulmonary hypertension care worldwide.
Arterial
Hypertension
Your Comprehensive Hub for Excellence in PAH Education
Recognized as the world's largest educational initiative of its kind, our program now extends well beyond pulmonary arterial hypertension (PAH) to encompass associated cardiovascular, pulmonary, connective-tissue, and rheumatic diseases. We continually innovate to meet the diverse needs of PH specialists through local in-person meetings, national conferences, immersive Masterclasses, and Minute CE®—the first ACCME-compliant micro-learning platform for point-of-care education. Building on this legacy, our new Learning Center once again elevates the standard, delivering adaptive resources, evidence-based tools, and cutting-edge strategies that empower healthcare professionals to improve patient lives.
Associated Diseases and Conditions of PH
Pulmonary Arterial Hypertension (PAH) is a progressive and potentially fatal condition that can be associated with various underlying conditions.
Educational Activities
Advance your expertise with our comprehensive collection of ACCME-accredited CME activities, featuring the latest research, expert insights, and evidence-based approaches in PAH care.
Advancing Patient-Centered Care in PAH
PH Management in Unique Patients and Conditions
New and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer
Right Heart Catheterization: Mastery of Precision Techniques
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Pulmonary Hypertension Management: Practice Trends and Updates
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson's Perspective
Risk Stratification Refinements with Inclusion of Hemodynamic Variables at Follow-up in Patients with Pulmonary Arterial Hypertension
Integrating Evidence for Improved Outcomes in PH
Update in Pediatric Pulmonary Hypertension
The Promise of Sotatercept in PAH
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
Updates From the 7th World Symposium Task Force
The Fundamentals of Pulmonary Hypertension
Essential Toolkit - Comprehensive educational slides and references
Resource Center
Stay at the forefront of PAH research with our curated collection of landmark studies, breakthrough therapies, and clinical trial results that are shaping the future of patient care.
Leading Global Experts
Our distinguished multidisciplinary faculty represents the pinnacle of expertise in pulmonary arterial hypertension, bringing together renowned clinicians, researchers, and thought leaders from the world's most prestigious medical institutions.
Vallerie V. McLaughlin
Richard N. Channick
Ioana Preston
Kelly Chin
Marsha Burks
Rajan Saggar
Richard Krasuski
Marc Humbert
Martha Kingman
Susanne McDevitt
Jean M. Elwing
Victor Moles
H. James Ford
Hilary M. DuBrock
Oksana A. Shlobin
Gustavo A. Heresi
Lucilla Piccari
